Susceptibility to winter vomiting disease: a sweet matter

@article{Rydell2011SusceptibilityTW,
  title={Susceptibility to winter vomiting disease: a sweet matter},
  author={Gustaf E. Rydell and Elin Kindberg and G{\"o}ran Larson and Lennart Svensson},
  journal={Reviews in Medical Virology},
  year={2011},
  volume={21}
}
Norovirus, the cause of winter vomiting disease, has emerged in recent years to be a major cause of sporadic and epidemic gastroenteritis worldwide. The virus has been estimated to cause >200 000 deaths each year in developing countries. Although the virus is highly contagious, volunteer and field studies have shown that a subset of individuals appears resistant to infections. A single nucleotide mutation (G428A) in the fucosyltransferase gene (FUT2) on chromosome 19 provides strong protection… Expand
Host Genetic Factors Affect Susceptibility to Norovirus Infections in Burkina Faso
TLDR
This is the first study identifying host genetic factors associated with susceptibility to NoV in an African population, and suggests that while the non-secretor phenotype provides protection; the Lewis b antigen is not necessary for GII infection. Expand
Norovirus Correlates of Protection
TLDR
This chapter summarizes the current knowledge on innate and adaptive immune responses targeting HuNoV revealed by challenge, preclinical and clinical studies and overviews the role of histo-blood group antigens (HBGA)-blocking antibodies, the use of hemagglutination inhibition (HAI) assay and stem cell-derived human intestinal enteroids (HIE)-based assay in the evaluation of norovirus vaccines. Expand
Host susceptibility to rotavirus infection and development of antibody-based immunotherapy
TLDR
An antibody-based therapy against rotavirus is developed, which may confer safe, immediate and efficient viral neutralization and protection and could be further developed and used as an alternative or complement to current vaccines. Expand
Innate Resistance and Susceptibility to Norovirus Infection
TLDR
Host genetic factors involved in innate or adaptive immunity or expression of pathogen receptors, including HBGA-expressing bacteria and bacteria inducing fucosylation in the gut, could be intermediary factors that govern norovirus susceptibility. Expand
Characterisation of a household norovirus outbreak occurred in Valencia (Spain)
TLDR
This study reinforces the idea that susceptibility to human NoV is both dependent on the HBGA profile of the individuals as well as on the viral genotype and variant, and shows that the immunity to NoV lasts for at least 1 year after infection. Expand
One more step toward understanding the immune response to norovirus.
TLDR
Study of epitope changes among the GII.4 variants supported the hypothesis that protective herd immunity drives the emergence of new GII-4 variants every 2– 4y ears. Expand
The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection
TLDR
This study provides new insights into the host genetic susceptibility to norovirus infections and evolution of the globally dominating GII.4 viruses. Expand
Norovirus: tribulation and possible trial
TLDR
Control of this infection at the community level would be ideal, but the development of vaccines against norovirus is in its infancy, and the elderly often have multiple medical problems needing longer hospital stay and are generally less able to clean up their body excretions, thereby helping to perpetuate any outbreak once it has started. Expand
Role of noroviruses as aetiological agents of diarrhoea in developing countries.
TLDR
This review summarizes the current knowledge of norovirus infection in developing countries and seeks to position infections with noroviruses among those of other enteropathogens in terms of disease burden in these regions. Expand
Relationship between GII.3 norovirus infections and blood group antigens in young children in Tunisia.
  • S. Ayouni, M. Estienney, +8 authors G. Belliot
  • Biology, Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2015
TLDR
The data showed that GII.3 NoVs could infect non-secretors, no binding was observed with saliva and G.3 baculovirus-expressed virus-like particles from the same symptomatic non- secretor individual, suggesting that other factors might also participate in NoV attachment in children and newborns. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 122 REFERENCES
Risk factors for infections with Norovirus gastrointestinal illness in Switzerland
TLDR
The findings are consistent with person-to-person transmission as the most important route of transmission for community-acquired, sporadic NV infection, in that 39% of all patients reported they had had contact with ill persons before their illness, and a substantial proportion of patients were part of family mini-outbreaks. Expand
Genetic susceptibility to symptomatic norovirus infection in Nicaragua
TLDR
Previous knowledge about the histo‐blood group antigens role in NoV disease in a population with different genetic background than North American and European is extended. Expand
Noroviruses everywhere: has something changed?
TLDR
The availability of new methods of detecting noroviruses has resulted in increased detection of these pathogens and advances in understanding of virus replication and structure should lead to development of strategies to prevent and treat these infections. Expand
High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution.
TLDR
The severe impact on patients and hospitals and the potential role of prolonged shedders as a reservoir for viral antigenic variants lead us to stress the importance of confinement of outbreaks of NoV infection that occur in hospitals. Expand
Association of histo-blood group antigens and susceptibility to norovirus infections.
TLDR
The association between susceptibility to NoV infection and being a secretor may be restricted to GGI NoV, and individuals with the HBGA type B may be protected against infection with GGI (but not GGII) NoVs. Expand
The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection
TLDR
This study provides new insights into the host genetic susceptibility to norovirus infections and evolution of the globally dominating GII.4 viruses. Expand
Mechanisms of GII.4 Norovirus Persistence in Human Populations
TLDR
Molecular mechanisms governing GII.4 epidemiology, susceptibility, and persistence in human populations suggest that the surface-exposed carbohydrate ligand binding domain in the norovirus capsid is under heavy immune selection and likely evolves by antigenic drift in the face of human herd immunity. Expand
Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations
TLDR
Observations suggest that the norovirus capsid evolves to evade the memory immune response while retaining its ability to bind any of several HBGAs, which allows escape from herd immunity. Expand
Characteristics of Human Calicivirus Enteritis in Intestinal Transplant Recipients
TLDR
Findings demonstrate that human calicivirus can be a significant pathogen in intestinal transplant recipients and potentially in other immunocompromised patients. Expand
Norwalk virus enteric illness acquired by swimming exposure.
TLDR
Results not only indicate that electron microscopy is insensitive in detecting Norwalk virus, but that it has the potential to mislead. Expand
...
1
2
3
4
5
...